Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Celine Caillet

Dr Celine Caillet

Celine Caillet

Research scientist

Medicine Quality, IDDO

Dr Céline Caillet has joined the Infectious Diseases Data Observatory as Scientific Coordinator of the Medicine Quality Scientific Group in 2015 to coordinate the scientific activities on medicine quality and was appointed Research Scientist – Medicine Quality in 2016. Céline is a pharmacist and former resident of the Hospital of Toulouse. She has experience in drug safety and has taken part in several research projects at the Center of Pharmacovigilance, Laboratory of Medical and Clinical Pharmacology of Toulouse, France. Following her MSc in Epidemiology and Public Health in Bordeaux, France, Céline completed her PhD in drug safety in Laos. During her PhD, Céline also taught pharmacology in the Department of Pharmacy at the University of Health Sciences, Vientiane.

Medicines are of vital importance in health systems, and access to quality-assured medicines is part of the basic right to health. Nevertheless, poor quality medical products, including medicines, vaccines and diagnostic devices, are widespread due to poor manufacture (substandard medicines) or deliberate falsification. These jeopardise national, regional and global attempts to improve access to effective health care because they lead to avoidable morbidity and mortality, waste financial resources, and contribute to drug resistance.

There are several ways to fight against poor-quality medicines. The medicine quality group of the Infectious Diseases Data Observatory aims at sharing expertise and collating information to increase understanding of the prevalence and distribution of poor quality medicines around the world. The group encourages discussion of poor quality medicine epidemiology, detection and prevention, and aims to facilitate improvement in the quality of medicines that patients actually take. The group also advocates for more investment in the regulation of medicine distribution and treatment adherence and interventions to improve medicine quality.

The medicine quality group in LOMWRU
Medicine quality screening devices' hands-on session with medicines regulators from the GMS countries
Medicines quality screening devices workshop with GMS medicines regulators in Vientiane to present the results of the work done by the medicine quality team